Dayvigo (Lemborexant)

lemborexant · Eisai Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Dayvigo (Lemborexant), covering 2025-04-24 to 2026-02-18. Get the full timeline:

Most recent: Clinical Trial Update: A Multicenter Observational Study of Lemborexant on Insomnia Patients With Psychiatric Disorders